vimarsana.com

Page 72 - நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nexstim Plc: Invitation to the Extraordinary General Meeting

Nexstim Plc: Invitation to the Extraordinary General Meeting  Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) invites shareholders to the Extraordinary General Meeting of the Company to decide on authorizations for the Board of Directors to decide on share issues and issuances of option rights and special rights to shares. The Extraordinary General Meeting will be held on Monday, March 1, 2021 commencing at 1 PM (EET) at the Nexstim Headquarters, Elimäenkatu 9 B (inner court), 4 th floor, 00510 Helsinki. The reception of persons who have registered for the meeting will commence at 12.30 PM (EET). Since the risk of getting infected by coronavirus is still significant, all shareholders are strongly encouraged to exercise their voting rights by proxy representation by the General Counsel of the Company. More information and instructions on authorising by proxy is available on the Company website

Nasdaq Nordic: Nasdaq Copenhagen welcomes BactiQuant A/S to Nasdaq First North Growth Market Denmark

Nasdaq Nordic: Nasdaq Copenhagen welcomes BactiQuant A/S to Nasdaq First North Growth Market Denmark Copenhagen February 5, 2021 - Nasdaq (Nasdaq: NDAQ) announces that trading in the BactiQuant A/S share (short name: BACTIQ) starts today on Nasdaq First North Growth Market Denmark. BactiQuant belongs to the industrial sector and is the 2nd company, which will be admitted to trading on Nasdaq Copenhagen in 2021 and is no. 5 on the Nasdaq Nordic Market . BactiQuant has developed a unique product for automated monitoring of the bacterial content in water within minutes. The technology is good for the environment, helping industries to manage water in a greener and more

Environmental Growth Chambers Selects Heliospectra s ELIXIA LED Lighting Solutions

SynAct carries out a directed share issue and raises proceeds of SEK 80 million - English version - Swedish version published 08:00 today

Sponsrat Sponsrat SynAct carries out a directed share issue and raises proceeds of SEK 80 million - English version - Swedish version published 08:00 today SynAct Pharma AB (publ) (”SynAct” or ”the Company”) has, in accordance with the announcement made in a press release yesterday, successfully completed a directed share issue of 1,600,000 shares at a price of SEK 50 per share (the “Directed Share Issue”). Due to the Directed Share Issue being multiple times over-subscribed by a large number of professional investors, the gross proceeds in the Directed Share Issue were increased from the SEK 55 million indicated in the Company’s press release yesterday. Through the Directed Share Issue, the Company will receive gross proceeds of SEK 80 million. The subscription price in the Directed Share Issue has been determined through an accelerated book building procedure performed by ABG Sundal Collier AB. The Directed Share Issue was multiple times over-

First North Denmark: Disciplinary decision from Nasdaq Copenhagen: Late disclosure of resolutions from the general meeting

(1) Nasdaq Copenhagen has reprimanded that a company with shares admitted to trading at Nasdaq First North Growth Market disclosed the resolutions from the general meeting 9 days after the general meeting was held. A resume of the decision is available in Decisions & Statements 2021 on the following link: https://www.nasdaq.com/solutions/decisions-sanctions-copenhagen In order to ensure transparency about the decisions from the exchange, the exchange publish decisions concerning a reprimand or a fine. This is stated in Nasdaq First North Growth Market Rulebook, section 6. Further information about Nasdaq s disciplinary procedures can be found on the following link: https://www.nasdaq.com/solutions/copenhagen-disciplinary-processes

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.